Cargando…

Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia.

Detalles Bibliográficos
Autores principales:	Shipman, R., Malcolm, A., Levy, J. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011360/ https://www.ncbi.nlm.nih.gov/pubmed/6190494

Ejemplares similares

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Myelogenic Leukaemia
Publicado: (1915)

Myelogenous Leukæmia and Its Treatment
por: Debove,
Publicado: (1910)

Factors influencing prognosis in adults with acute myelogenous leukaemia.
por: Crowther, D., et al.
Publicado: (1975)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
por: Hu, C. W., et al.
Publicado: (2019)

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.
por: Trent, J. M., et al.
Publicado: (1983)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
por: Marie, J. P., et al.
Publicado: (1988)

Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia
por: Dalley, C D, et al.
Publicado: (2001)

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
por: Lee, C-Y, et al.
Publicado: (2007)

Early central nervous system involvement in adults with acute non-myelogenous leukaemia.
por: Lister, T. A., et al.
Publicado: (1977)

Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.
por: Rohatiner, A. Z.
Publicado: (1984)

Familial platelet disorders with a predisposition to acute myelogenous leukaemia: a RUNX1 update
por: Rossini, J, et al.
Publicado: (2012)

Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents
por: Ding, Yahui, et al.
Publicado: (2018)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
por: Cowan-Jacob, Sandra W., et al.
Publicado: (2006)

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
por: Sedlmayr, P., et al.
Publicado: (1992)

Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India
por: Anand, Maninder Singh, et al.
Publicado: (2012)

OGG1 rs1052133 Polymorphism and Genetic Susceptibility to Chronic Myelogenous Leukaemia
por: Hassan, Fathelrahman M
Publicado: (2019)

Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia
por: Ghosn, Youssef, et al.
Publicado: (2019)

The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
por: Naka, Kazuhito, et al.
Publicado: (2020)

Highly precise breakpoint detection of chromosome balanced translocation in chronic myelogenous leukaemia: Case series
por: Yang, Chuanchun, et al.
Publicado: (2022)

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
por: Powles, R. L., et al.
Publicado: (1977)

Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia
por: Senda, Miho, et al.
Publicado: (2016)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning
por: Topaly, J, et al.
Publicado: (2002)

A Massive Right Atrial Mass in Chronic Myelogenous Leukaemia: A Case Report and Literature Review
por: Benjanuwattra, Juthipong, et al.
Publicado: (2022)

Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
por: Fordham, S E, et al.
Publicado: (2015)

T cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
por: Hawkins, Edwin D, et al.
Publicado: (2016)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

Chemical characterization of non‐psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells
por: Anceschi, Lisa, et al.
Publicado: (2022)

Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
por: Denham, S., et al.
Publicado: (1980)

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
por: Kodama, Yuko, et al.
Publicado: (2012)

Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
por: Corrado, Chiara, et al.
Publicado: (2016)

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
Publicado: (1978)

Applications of Microarray Technology to Acute Myelogenous Leukemia
por: Goswami, Rashmi S., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_79lejtsope4nggium4vi5n65ij